Alcohol Dependence
Alcohol dependence is a complex disorder characterized by a cluster of cognitive, behavioral, and physiological symptoms, where an individual continues to consume alcohol despite experiencing significant alcohol-induced impairment or distress. Alcohol impacts nearly all human organs, and its excessive use is associated with a wide range of physical, mental, and social harms. Globally, alcohol abuse represents a serious public health challenge, contributing to 4% of the worldwide burden of disease, a figure comparable to the impact of tobacco use and hypertension[1].
The vulnerability to alcohol dependence is influenced by both genetic and environmental factors, with a substantial genetic component. Studies involving twins and adopted individuals estimate that genetic factors account for 40-60% of the differences in individual susceptibility to alcohol dependence[2]. This phenotypic diversity is reflected at the molecular level, where many genetic loci, each with small to modest effects, are thought to contribute to the risk, particularly in individuals of European descent [3].
Research has identified numerous genes implicated in alcohol dependence through various approaches. Candidate gene studies have pointed to genes within classical neurotransmitter systems, such as dopaminergic (e.g., MAOA, COMT, DRD2), serotoninergic (e.g., SLC6A4, HTR2B), GABAergic (e.g., GABRA2, GABRG1), and cholinergic (e.g., CHRM2, CHRNA5) pathways. Other implicated systems include non-classical neurotransmitter pathways (e.g., CRHR1), the ethanol metabolic pathway (e.g., ADH1B, ADH1C, ADH4, ALDH2), and the opioidergic signaling pathway (e.g., OPRM1, OPRD1, OPRK1). More recently, genome-wide association studies (GWAS) have further elucidated the genetic architecture of alcohol dependence, identifying novel risk loci[4]. These studies suggest that hundreds of genetic variants may contribute modestly to alcohol dependence risk. Specific genetic regions have been identified that are associated with alcohol dependence, with some reaching genome-wide significance, and these associations can sometimes be specific to particular populations, such as those of European descent[3].
Limitations
Section titled “Limitations”Research into the genetics of alcohol dependence, particularly through genome-wide association studies (GWAS), faces several inherent limitations that impact the interpretation and generalizability of findings. These challenges stem from methodological constraints, the complex nature of the phenotype, and the intricate genetic architecture of the trait.
Methodological and Statistical Constraints
Section titled “Methodological and Statistical Constraints”Genome-wide association studies for alcohol dependence have often been underpowered, necessitating the accumulation of significantly more cases to robustly identify genetic variants. The effect sizes observed for individual single nucleotide polymorphisms (SNPs) are typically very small, contributing less than 0.25% of the variance in risk, which suggests that hundreds of genetic variants each make only modest contributions[5]. This low power means that many true associations may be missed, and the selection of “top hits” in discovery samples can overestimate their true effect sizes, complicating subsequent attempts at replication [5].
The difficulty in replicating findings is further compounded by these small effect sizes and the sheer number of contributing variants. For example, some studies have reported a lack of replication for SNPs previously identified as strongly associated in other alcoholism GWAS [5]. Achieving a high probability of replicating a true association with such modest effects demands extremely stringent statistical thresholds and exceptionally large sample sizes, which are often not practically feasible [5]. These constraints highlight the challenges in confidently pinpointing specific genetic contributions and underscore the ongoing need for extensive meta-analyses across numerous research cohorts.
Phenotypic Complexity and Population Heterogeneity
Section titled “Phenotypic Complexity and Population Heterogeneity”The accurate definition and measurement of alcohol dependence and related phenotypes pose substantial challenges, as variations in assessment methodologies can undermine the robustness of research findings[5]. For instance, measures of current alcohol consumption may utilize truncated scales that inadequately characterize individuals with highly elevated consumption levels, or they might reflect past drinking patterns rather than present ones, especially in older populations whose consumption may have declined [5]. Such inconsistencies in phenotypic ascertainment introduce both clinical and genetic heterogeneity, making it difficult to integrate data across diverse studies and achieve consistent results.
Moreover, efforts to increase sample sizes to improve statistical power often involve including participants from varied cultural and ethnic backgrounds, which can inadvertently heighten population heterogeneity [5]. Genetic variants, such as those within the ADH1C gene, may exhibit differential associations across ancestral groups; for example, a significantly higher risk for carriers of the ADH1C*2 allele has been reported in East Asian populations, but its role in European populations remains less clear [5]. This demographic variability necessitates careful consideration of ancestral background when interpreting genetic findings and assessing their generalizability across diverse global populations.
Elusive Genetic Architecture and Translational Challenges
Section titled “Elusive Genetic Architecture and Translational Challenges”The genetic architecture of alcohol dependence appears to be highly polygenic and complex, with numerous genetic variants each contributing only a minute fraction to the overall risk[5]. This phenomenon, often referred to as “missing heritability,” implies that the sum of currently identified common variants explains only a small proportion of the estimated genetic influence, suggesting that many more variants, potentially including rare ones or those involved in complex gene-environment interactions, have yet to be discovered. The subtle individual effects of these numerous variants make it challenging to fully characterize the underlying biological pathways involved.
Consequently, translating current GWAS findings for alcohol dependence into practical clinical applications, such as novel drug discovery or clinically useful prediction of individual risk, remains a significant challenge[5]. While the continued accumulation of GWAS data may eventually prove valuable for improved genetic risk differentiation in biological psychiatry research, the modest individual contributions of identified variants currently limit their utility for precise clinical prediction or the development of targeted therapeutic interventions [5]. This gap between statistical association and clinical utility underscores the ongoing need for comprehensive research to unravel the intricate interplay of genetic and environmental factors.
Variants
Section titled “Variants”Genetic variants play a significant role in an individual’s susceptibility to alcohol dependence by influencing alcohol metabolism, neurotransmitter systems, and various metabolic pathways. These variations can alter gene activity, affecting how the body processes alcohol, how the brain responds to its effects, and overall cellular function. Understanding these genetic contributions helps to illuminate the complex biological underpinnings of alcohol dependence.
A cluster of alcohol dehydrogenase (ADH) genes, including ADH1B, ADH1C, and ADH4, are central to the body’s primary alcohol metabolism pathway. The ADH1B gene, with variants such as rs1229984 , rs2066702 , and rs2075633 , encodes an enzyme that converts alcohol into acetaldehyde, a toxic compound. Certain alleles of ADH1Blead to a faster conversion, causing unpleasant symptoms like flushing and nausea, which can act as a protective factor against developing alcohol dependence[6]. Similarly, ADH1C (e.g., rs1612735 , rs1614972 , rs12639833 ) and ADH4 (e.g., rs5860563 , rs17028615 , rs6822348 ) also contribute to alcohol breakdown, and their variants can impact the rate of alcohol clearance, thereby influencing drinking patterns and risk of dependence [7]. The ADH gene cluster, located on chromosomal region 4q, is recognized as a consistently replicated locus contributing to alcohol phenotypes [8], with some variants showing genome-wide significant association with alcohol dependence[9].
Variants within the DRD2 gene (e.g., rs4936277 , rs61902812 ), which encodes the dopamine receptor D2, are implicated in alcohol dependence through their influence on the brain’s reward system.DRD2 is a key component of dopaminergic signaling, which mediates pleasure, motivation, and reinforcement behaviors. Genetic variations in DRD2 can alter receptor density or function, affecting an individual’s sensitivity to dopamine and their response to alcohol’s rewarding effects. This can influence impulsivity, craving, and the propensity for developing addictive behaviors, as alterations in dopamine signaling are strongly linked to substance use disorders [10].
Other genes, such as GCKR, FTO, and SLC39A8, contribute to alcohol dependence through their roles in broader physiological processes.GCKR (e.g., rs1260326 ) encodes glucokinase regulatory protein, involved in glucose and lipid metabolism, and its variants might influence metabolic responses to alcohol or overall metabolic health, which can be affected by chronic alcohol consumption. TheFTO gene (e.g., rs1421085 , rs11075992 ), primarily known for its association with obesity and energy balance, may influence alcohol dependence through shared pathways related to reward, appetite regulation, or hypothalamic function.SLC39A8 (e.g., rs13107325 ) encodes a zinc transporter, and variants in this gene could affect zinc homeostasis, which is vital for neurotransmitter function, immune response, and antioxidant defense. Disruptions in these processes can impact brain health and vulnerability to alcohol’s neurotoxic effects or withdrawal symptoms.
Finally, variants in genes like CAMKMT (e.g., rs540606 , rs570436 ) and long intergenic non-coding RNAs (lncRNAs) such as LINC01833 (co-located with CAMKMT) and LINC02661 (e.g., rs7906104 ) suggest more intricate regulatory mechanisms. CAMKMT is involved in calcium/calmodulin-dependent protein kinase signaling, a crucial pathway for neuronal plasticity and learning, which are often dysregulated in addiction. LncRNAs like LINC01833 and LINC02661do not code for proteins but play significant roles in regulating gene expression, influencing chromatin structure, transcription, and post-transcriptional processes. Variants in these regulatory regions or signaling genes could subtly alter brain function, stress responses, or neuronal connectivity, thereby contributing to the development and persistence of alcohol dependence through complex indirect mechanisms.
Key Variants
Section titled “Key Variants”| RS ID | Gene | Related Traits |
|---|---|---|
| rs1229984 rs2066702 rs2075633 | ADH1B | alcohol drinking upper aerodigestive tract neoplasm body mass index alcohol consumption quality alcohol dependence measurement |
| rs1612735 rs1614972 rs12639833 | ADH1C | alcohol dependence |
| rs13107325 | SLC39A8 | body mass index diastolic blood pressure systolic blood pressure high density lipoprotein cholesterol measurement mean arterial pressure |
| rs4936277 | DRD2 - TMPRSS5 | anxiety measurement depressive symptom measurement neuroticism measurement alcohol dependence self reported educational attainment |
| rs1260326 | GCKR | urate measurement total blood protein measurement serum albumin amount coronary artery calcification lipid measurement |
| rs1421085 rs11075992 | FTO | body mass index obesity energy intake pulse pressure measurement lean body mass |
| rs540606 rs570436 | CAMKMT - LINC01833 | alcohol dependence obstructive sleep apnea |
| rs5860563 rs17028615 rs6822348 | ADH4 | sex hormone-binding globulin measurement free cholesterol measurement, high density lipoprotein cholesterol measurement total cholesterol measurement, high density lipoprotein cholesterol measurement lipid measurement, high density lipoprotein cholesterol measurement cholesteryl ester measurement, high density lipoprotein cholesterol measurement |
| rs7906104 | LINC02661 | alcohol use disorder measurement, alcohol consumption quality alcohol dependence |
| rs61902812 | DRD2 - TMPRSS5 | smoking cessation alcohol dependence |
Classification, Definition, and Terminology
Section titled “Classification, Definition, and Terminology”Alcohol dependence is a complex trait explored in various research. Studies have conducted family-based association analyses of alcohol dependence criteria and its severity[11]. The term “alcoholism” is also used in research, with investigations into its potential subtyping [12] and methods for its assessment in general community surveys [5].
From a public health perspective, alcohol abuse is identified as a significant global issue, contributing to 4% of the worldwide disease burden, a level comparable to the impact of tobacco and hypertension[13].
Signs and Symptoms of Alcohol Dependence
Section titled “Signs and Symptoms of Alcohol Dependence”Alcohol dependence is characterized by a range of symptoms that reflect impaired control over alcohol use, preoccupation with alcohol, continued use despite adverse consequences, and physiological adaptations[5].
Typical Presentations
Section titled “Typical Presentations”Individuals experiencing alcohol dependence may present with several key indicators, including:
- Craving for alcohol: A powerful and persistent urge or desire to consume alcohol [5].
- Dangerous use: Engaging in alcohol consumption in situations that pose physical hazards, such as driving or operating machinery [5].
- Tolerance: Requiring increased amounts of alcohol to achieve the desired effect, or experiencing a significantly reduced effect from the same amount of alcohol [5].
- Loss of control: Difficulty in limiting or stopping alcohol intake once drinking has commenced [5].
- Significant time investment: Devoting substantial time to activities related to alcohol, such as obtaining it, using it, or recovering from its effects [5].
- Activities given up: Reducing or abandoning important social, occupational, or recreational activities due to alcohol use [5].
- Continued use despite harm: Persisting in alcohol use even with awareness that it is causing or worsening physical or psychological problems [5].
In general community samples, alcohol dependence often presents in a mild form. Studies indicate that a large percentage of individuals who meet the criteria for alcohol dependence report only 3 or 4 symptoms, with a much smaller percentage reporting all 7 dependence symptoms. Additionally, a notable number of affected individuals may not report weekly drinking to the point of intoxication, and a minority might not even consume 5 or more standard drinks in a single day on a weekly basis[5].
Measurement Approaches
Section titled “Measurement Approaches”The assessment of alcohol dependence symptoms typically involves structured interviews, such as those employing the Composite International Diagnostic Interview-Short Form (CIDI-SF)[5]. The process often begins by asking individuals about the highest number of drinks they have ever consumed within a 24-hour period [5]. For those who report consuming 4 or more drinks in a single day, a set of 7 specific questions are then posed to evaluate the presence of alcohol dependence symptoms[5].
These questions cover criteria like craving, dangerous use (a criterion for alcohol abuse), tolerance, loss of control, time spent on alcohol, activities given up due to alcohol, and continued use despite awareness of harm [5]. While most of these symptom questions are binary (yes/no), those assessing “loss of control” and “activities given up” may offer up to 5 possible responses to capture a broader range of experiences [5]. Individuals who report consuming a maximum of 1 to 3 drinks in a day are often considered “light social drinkers” and may be assigned a score of zero for alcohol-related symptoms in research studies [5]. Factor scores can be derived from the total number of reported symptoms for further analysis [5].
Variability
Section titled “Variability”Alcohol dependence exhibits considerable variability in its presentation among individuals. The severity of the condition can vary significantly; for example, a large majority of those diagnosed may only report a few symptoms, suggesting a spectrum of mild to more severe presentations[5]. Drinking patterns among individuals meeting dependence criteria also vary, with some not reporting frequent heavy drinking despite their diagnosis [5]. Assessment tools often accommodate this variability by allowing a range of responses for certain symptoms, such as loss of control and activities given up, rather than just simple binary options [5].
Causes of Alcohol Dependence
Section titled “Causes of Alcohol Dependence”Alcohol dependence is a complex condition influenced by a combination of genetic and environmental factors.
Genetic Factors
Section titled “Genetic Factors”Research indicates that genetic factors play a significant role in the development of alcohol dependence. Studies, including twin and adoption analyses, have provided substantial evidence for a genetic predisposition[14].
Numerous specific genes have been identified as potential risk loci through candidate gene approaches. These genes are involved in various biological pathways:
- Neurotransmitter signaling systems: Genes impacting dopaminergic systems (e.g., MAOA, COMT, NCAM1-TTC12-ANKK1-DRD2), serotoninergic systems (e.g., SLC6A4, HTR2B) [15], GABAergic systems (e.g., GABRA2, GABRG1) [16], and cholinergic systems (e.g., CHRM2, CHRNA5-CHRNA3-CHRNB4) have been implicated.
- Ethanol metabolic pathway:Genes such as ADH1B, ADH1C, ADH4, and ALDH2 are associated with alcohol dependence.
- Opioidergic signaling pathway: Genes like OPRM1, OPRD1, and OPRK1 are also considered risk factors.
- Other systems: Non-classical neurotransmitter systems, such as CRHR1, have been identified.
More recently, genome-wide association studies (GWASs) have uncovered additional genetic regions associated with alcohol dependence[4]. For instance, one GWAS implicated a specific region on chromosome 11 [17], while a meta-analysis identified three new loci [18]. The nuclear transcription factor PKNOX2 has also been identified as a candidate gene, particularly in women of European origin [19].
Environmental Factors
Section titled “Environmental Factors”Environmental influences also contribute to the risk of developing alcohol dependence, often interacting with genetic predispositions[20]. These environmental factors can range from early life exposures to influences throughout adolescence and adulthood [21].
Specific environmental exposures include:
- Maternal alcohol consumption: Studies in mice have shown that maternal alcohol consumption can increase sphingosine levels in the brains of offspring [22].
- Early developmental alcohol exposure: Alcohol exposure during early neurulation has been observed to alter gene expression [23].
Biological Background
Section titled “Biological Background”Alcohol dependence is a complex disorder characterized by a range of cognitive, behavioral, and physiological symptoms, where individuals continue to consume alcohol despite significant alcohol-related harm or distress. Alcohol misuse poses a global public health challenge, impacting numerous human organs and contributing significantly to the worldwide burden of disease[1].
Research indicates that alcohol dependence has a substantial genetic component. Twin and adoption studies estimate that genetic factors account for 40-60% of the variability in alcohol dependence among individuals[2]. This genetic vulnerability is thought to involve many genetic loci, each with small to modest effects, particularly in populations of European ancestry [4].
Genetic studies have identified several biological pathways and specific genes associated with alcohol dependence through the candidate gene approach[24]. These include:
- Classical Neurotransmitter Signaling Systems:
- Dopaminergic system: Genes such as MAOA, COMT, and the NCAM1-TTC12-ANKK1-DRD2 cluster.
- Serotoninergic system: Genes like SLC6A4 and HTR2B.
- GABAergic system: Genes including GABRA2 and GABRG1.
- Cholinergic system: Genes such as CHRM2 and the CHRNA5-CHRNA3-CHRNB4 cluster.
- Non-classical Neurotransmitter Signaling Systems: For example, the CRHR1 gene.
- Ethanol Metabolic Pathway: Genes involved in alcohol breakdown, such as ADH1B, ADH1C, ADH4, and ALDH2.
- Opioidergic Signaling Pathway: Genes like OPRM1, OPRD1, and OPRK1.
More recently, genome-wide association studies (GWAS) have emerged as a powerful tool for identifying genetic susceptibility variants in complex disorders, including psychiatric conditions [4]. For alcohol dependence, initial GWAS have suggested new susceptibility loci whose gene products are implicated in cellular signaling, gene regulation, development, and cell adhesion.
Pathways and Mechanisms
Section titled “Pathways and Mechanisms”The development of alcohol dependence is significantly influenced by genetic factors, which are thought to mediate the condition at a molecular level through numerous genetic loci, each contributing small to modest effects[25]. Research has identified various risk genes through candidate gene approaches, primarily within several key biological systems.
Many implicated risk genes belong to classical neurotransmitter signaling systems. These include the dopaminergic system, with genes such as MAOA, COMT, and the cluster NCAM1-TTC12-ANKK1-DRD2 [10]. The dopamine D3 receptor, in particular, has been shown to play an essential role in alcohol-seeking behaviors and relapse [26]. Other classical systems include the serotoninergic system (e.g., SLC6A4 and HTR2B), GABAergic system (e.g., GABRA2 and GABRG1), and cholinergic systems (e.g., CHRM2 and CHRNA5-CHRNA3-CHRNB4) [27].
Beyond classical neurotransmission, non-classical systems, such as those involving CRHR1, and the opioidergic signaling pathway, including genes like OPRM1, OPRD1, and OPRK1, have also been implicated [28]. The ethanol metabolic pathway itself is a significant area of genetic influence, with genes such as ADH1B, ADH1C, ADH4, and ALDH2 playing a role [29].
Genome-wide association studies (GWAS) have further revealed susceptibility loci for alcohol dependence, with products involved in cellular signaling, gene regulation, development, and cell adhesion[4]. Analyses using tools like ALIGATOR have highlighted various cellular mechanisms in European populations. These include responses to hormonal stimuli, anatomical structural homeostasis, phosphorylation, NADPH oxidase complex activity, glucocorticoid stimulus, cellular responses to insulin stimulus, the insulin receptor signaling pathway, and sulfation[25]. When individual genes from these analyses were examined, signals related to calcium and potassium signaling, as well as glutamate receptor subunits, were observed, suggesting their direct involvement in addiction[25].
An Australian/Dutch GWAS also reported findings related to genes encoding transporters, cell adhesion molecules, and cytoskeleton proteins [30]. Structural homeostasis is known to contribute to the regulation of drug-induced neuroplasticity through its influence on scaffold proteins and signal transduction [31].
Ethical and Social Considerations
Section titled “Ethical and Social Considerations”Alcohol dependence is recognized as a significant global public health problem. It contributes substantially to the worldwide burden of disease, with an impact comparable to that of tobacco and hypertension[32].
Frequently Asked Questions About Alcohol Dependence
Section titled “Frequently Asked Questions About Alcohol Dependence”These questions address the most important and specific aspects of alcohol dependence based on current genetic research.
1. My parent struggled; will I definitely have alcohol problems too?
Section titled “1. My parent struggled; will I definitely have alcohol problems too?”Not necessarily, but your risk is higher. Genetic factors account for 40-60% of susceptibility to alcohol dependence, meaning you inherit some vulnerability. However, your environment and personal choices play a significant role too, so a family history doesn’t guarantee you’ll develop the condition.
2. Why do some people get addicted to alcohol faster than others?
Section titled “2. Why do some people get addicted to alcohol faster than others?”Your genetic makeup can make you more vulnerable. Variations in genes involved in neurotransmitter systems, like those for dopamine (e.g., DRD2) or serotonin (e.g., SLC6A4), can influence how you experience alcohol’s effects and your propensity for dependence. These genetic differences, combined with environmental factors, contribute to how quickly someone might develop a problem.
3. Can I overcome my family’s alcohol history with healthy choices?
Section titled “3. Can I overcome my family’s alcohol history with healthy choices?”Yes, you absolutely can influence your risk. While genetic factors contribute 40-60% to susceptibility, your lifestyle choices, like choosing not to drink or drinking moderately, are powerful protective factors. Understanding your genetic vulnerability can empower you to make informed decisions that significantly reduce your chances of developing alcohol dependence.
4. Does my ethnic background change how alcohol affects me?
Section titled “4. Does my ethnic background change how alcohol affects me?”Yes, your ethnic background can influence how your body processes alcohol and your risk. For example, some populations, particularly individuals of East Asian descent, may carry specific variants in genes like ADH1C, which are involved in alcohol metabolism. These variants can lead to different physiological responses and potentially alter your risk profile compared to other ancestral groups.
5. My sibling drinks a lot, but I don’t. Why are we so different?
Section titled “5. My sibling drinks a lot, but I don’t. Why are we so different?”Even with shared genetics, individual differences are common due to the complex nature of alcohol dependence. While genetic factors account for a significant portion of risk, many genes each contribute only a small effect, and environmental influences vary even between siblings. These slight genetic variations and unique life experiences can lead to very different outcomes.
6. What makes me more vulnerable to alcohol dependence?
Section titled “6. What makes me more vulnerable to alcohol dependence?”Your vulnerability is a mix of your genes and life experiences. Genes influencing your brain’s reward system, like those in dopaminergic (e.g., DRD2) or opioidergic (e.g., OPRM1) pathways, can make you more susceptible to alcohol’s reinforcing effects. Combined with environmental factors, these genetic predispositions shape your individual risk.
7. Would a genetic test tell me if I’m at high risk?
Section titled “7. Would a genetic test tell me if I’m at high risk?”Currently, a single genetic test can’t definitively predict your personal risk for alcohol dependence. While research has identified hundreds of genetic variants associated with risk, each contributes only a very small amount, and their combined effect is complex. Genetic testing can offer insights into general predispositions, but it’s not a diagnostic tool for individual risk prediction.
8. Why do some people feel alcohol’s effects differently?
Section titled “8. Why do some people feel alcohol’s effects differently?”Your unique genetic makeup significantly influences how your body processes and reacts to alcohol. Genes involved in alcohol metabolism, like ADH1B and ALDH2, or those in neurotransmitter systems, can alter how quickly you feel intoxicated, how severe your hangovers are, and your overall response. This explains why experiences vary widely among individuals.
9. Why is it so hard for some people to stop drinking once they start?
Section titled “9. Why is it so hard for some people to stop drinking once they start?”For some, genetic variations make it harder to stop due to their impact on brain reward systems and impulse control. Genes linked to dopaminergic (e.g., MAOA) and serotoninergic (e.g., SLC6A4) pathways can affect how your brain experiences pleasure and manages cravings, contributing to the powerful grip alcohol can have once dependence develops.
10. Why can’t scientists pinpoint one “alcohol addiction gene”?
Section titled “10. Why can’t scientists pinpoint one “alcohol addiction gene”?”Alcohol dependence is a highly complex, polygenic disorder, meaning hundreds of genetic variants, each with very small effects, contribute to the overall risk. There isn’t a single “addiction gene” because it’s the cumulative impact of many genes interacting with environmental factors that determines susceptibility. This complex genetic architecture makes identifying a single cause challenging.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
Section titled “References”[1] Rehm, J., et al. “Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders.”Lancet vol. 373, 2009, pp. 2223–2233.
[2] Goldman, D., Oroszi G., and F. Ducci. “The genetics of addictions: Uncovering the genes.” Nature Reviews Genetics vol. 6, 2005, pp. 521–532.
[3] Zuo, L., et al. “A novel, functional and replicable risk gene region for alcohol dependence identified by genome-wide association study.”PLoS One, vol. 6, no. 11, 2011, e26726.
[4] Bierut, L. J., et al. “A Genome-Wide Association Study of Alcohol Dependence.”JAMA, vol. 303, no. 9, 2010, pp. 856-864.
[5] Heath, A. C., et al. “Alcoholism; Genome-Wide Association; Quantitative-Trait; Non-Replication.” Biological Psychiatry, 2011.
[6] Li, D., et al. “Strong association of the alcohol dehydrogenase 1B gene (ADH1B) with alcohol dependence and alcohol-induced medical diseases.”Biological Psychiatry, vol. 69, no. 6, 2011, pp. 504-512.
[7] Li, D., et al. “Further clarification of the contribution of the ADH1C gene to vulnerability of alcoholism and selected liver diseases.” Human Genetics, vol. 131, no. 8, 2012, pp. 1361-1374.
[8] Treutlein, J., et al. “Genome-Wide Association Study Identifies New Susceptibility Loci for Alcohol Dependence.”Biological Psychiatry, vol. 65, no. 1, 2009, pp. 70-76.
[9] Frank, J., et al. “Genome-wide significant association between alcohol dependence and a variant in the ADH gene cluster.”Addiction Biology, vol. 17, no. 1, 2012, pp. 171-180.
[10] Bau, C. H. D., et al. “Dopamine D2 receptor gene and alcoholism: a meta-analysis.” Alcohol and Alcoholism, vol. 36, no. 5, 2001, pp. 466-474.
[11] Hesselbrock, Victor, et al. “Family-based association analysis of alcohol dependence criteria and severity.”Alcohol. Clin. Exp. Res., vol. 38, 2014, pp. 354–366.
[12] Bucholz, K. K., et al. “Can We Subtype Alcoholism? A Latent Class Analysis of Data from Relatives of Alcoholics in a Multicenter Family Study of Alcoholism.” Alcoholism: Clinical and Experimental Research, vol. 20, no. 8, 1996, pp. 1462-1471.
[13] World Health Organization. Management of Substance Abuse Team. Global Status Report on Alcohol and Health. World Health Organization, 2011.
[14] Cloninger, C. R., et al. “Inheritance of alcohol abuse. Cross-fostering analysis of adopted men.” Archives of General Psychiatry, vol. 38, 1981, pp. 861–868.
[15] Wojnar, M., et al. “Influence of impulsivity, suicidality and serotonin genes on treatment outcomes in alcohol dependence.”Psychiatria Polska, vol. 40, 2006, pp. 985–994.
[16] Chang, Y. T., et al. “Association of the gamma-aminobutyric acid A receptor gene cluster with alcohol dependence in Taiwanese Han.”Molecular Psychiatry, vol. 7, 2002, pp. 828–829.
[17] Edenberg, H. J., et al. “Genome-wide association study of alcohol dependence implicates a region on chromosome 11.”Alcohol Clinical and Experimental Research vol. 34, 2010, pp. 840–852.
[18] Wang, K. S., et al. “A meta-analysis of two genome-wide association studies identifies 3 new loci for alcohol dependence.”J Psychiatr Res, vol. 45, no. 11, 2011, pp. 1419–1425.
[19] Chen, X., et al. “The nuclear transcription factor PKNOX2 is a candidate gene for substance dependence in European-origin women.” PLoS One, vol. 6, no. 1, 2011, e16002.
[20] van der Zwaluw, C. S., and R. C. Engels. “Gene-environment interactions and alcohol use and dependence: current status and future challenges.” Addiction vol. 104, 2009, pp. 907–914.
[21] Kendler, K. S., et al. “Genetic and environmental influences on alcohol, caffeine, cannabis, and nicotine use from early adolescence to middle adulthood.”Archives of General Psychiatry vol. 65, 2008, pp. 674–682.
[22] Dasgupta, S., et al. “Maternal alcohol consumption increases sphingosine levels in the brains of progeny mice.” Neurochemical Research, vol. 32, 2007, pp. 2217–2224.
[23] Zhou, F. C., et al. “Alteration of gene expression by alcohol exposure at early neurulation.” BMC Genomics, vol. 12, 2011, p. 124.
[24] Dick, D. M., and T. Foroud. “Candidate genes for alcohol dependence: a review of genetic association studies.”Alcoholism: Clinical and Experimental Research, vol. 27, no. 11, 2003, pp. 1779-1785.
[25] Kendler, K. S., et al. “Genomewide Association Analysis of Symptoms of Alcohol Dependence in the Molecular Genetics of Schizophrenia (MGS2) Control Sample.”Alcoholism: Clinical and Experimental Research, vol. 35, no. 5, 2011, pp. 963-975.
[26] Vengeliene, V., et al. “The Dopamine D3 Receptor Plays an Essential Role in Alcohol-Seeking and Relapse.” FASEB J., vol. 20, no. 13, 2006, pp. 2223–2233.
[27] Gelernter, J., et al. “DRD2/ANKK1 variation and alcohol dependence: replication in an African American sample.”Biological Psychiatry, vol. 60, no. 9, 2006, pp. 977-981.
[28] Gelernter, J., and H. R. Kranzler. “Genetics of Alcohol Dependence.”Current Psychiatry Reports, vol. 11, no. 2, 2009, pp. 111-118.
[29] Hurley, T. D., and H. J. Edenberg. “Genes Encoding Enzymes Involved in Ethanol Metabolism.” Alcohol Research: Current Reviews, vol. 34, no. 3, 2012, pp. 339-344.
[30] Lind, P. A., et al. “A Genome-Wide Association Study of Alcohol Dependence in a Large Australian Sample.”Biological Psychiatry, vol. 68, no. 1, 2010, pp. 58-65.
[31] Szumlinski, K. K., et al. “Regulation of Drug-Induced Neuroplasticity by Scaffold Proteins and Signal Transduction.” Frontiers in Bioscience (Elite Edition), vol. 1, 2008, pp. 117-130.
[32] World Health Organization Department of Mental Health and Substance Abuse. Global Status Report on Alcohol. World Health Organization, 2004.